Chirality in New Drug Development
- 1 October 1994
- journal article
- review article
- Published by Springer Nature in Clinical Pharmacokinetics
- Vol. 27 (4) , 249-255
- https://doi.org/10.2165/00003088-199427040-00001
Abstract
No abstract availableKeywords
This publication has 27 references indexed in Scilit:
- Bioequivalence requirements for generic productsPharmacology & Therapeutics, 1994
- Chirality and its importance in drug development: what are the issues?Biochemical Society Transactions, 1991
- Stereoselectivity in clinical pharmacokinetics and drug developmentEuropean Journal of Drug Metabolism and Pharmacokinetics, 1990
- Racemates versus enantiomers in drug development: Dogmatism or pragmatism?Chirality, 1990
- Stereoselective drug disposition: potential for misinterpretation of drug disposition data.British Journal of Clinical Pharmacology, 1988
- Age-associated stereoselective alterations in hexobarbital metabolismClinical Pharmacology & Therapeutics, 1988
- Importance of Drug Enantiomers in Clinical PharmacologyDrugs, 1985
- Effects of d,l-verapamil on atrioventricular conduction in relation to its stereoselective first-pass metabolismClinical Pharmacology & Therapeutics, 1985
- Stereoselective disposition of ibuprofen enantiomers in man.British Journal of Clinical Pharmacology, 1985
- Stereoselective first‐pass metabolism of highly cleared drugs: studies of the bioavailability of L‐ and D‐verapamil examined with a stable isotope technique.British Journal of Clinical Pharmacology, 1984